Overview

Oral Dexamethasone for Treatment of Migraine

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to determine if a single dose of oral dexamethasone at the time of discharge from the emergency department (ED) [after successful treatment] prevents rebound headache. Hypothesis: That single dose oral dexamethasone 8mg reduces the proportion of patients who suffer rebound headache after treatment for migraine in the ED.
Phase:
Phase 4
Details
Lead Sponsor:
The Joseph Epstein Centre for Emergency Medicine Research
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate